Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/36358
Title: | Development of a UPLC-MS/MS bioanalytical method for the pharmacokinetic study of (-)-epiafzelechin, a flavan-3-ol with osteoprotective activity, in C57BL/6J mice | Authors: | Wong, KC Law, MC Wong, MS Chan, TH |
Issue Date: | 15-Sep-2014 | Source: | Journal of chromatography b-analytical technologies in the biomedical and life sciences, 15 Sept. 2014, v. 967, p. 162-167 | Abstract: | (-)-Epiafzelechin is a flavan-3-ol commonly found in plant source. Biological studies suggested that (-)epiafzelechin may have anti-inflammatory, anti-oxidant and bone-protective effect. However, it's in vivo efficacy remains to be demonstrated. A specific detection method for (-)-epiafzelechin was successfully developed by using UPLC-MS/MS to quantify the amount of (-)-epiafzelechin present in mice plasma after a liquid-liquid extraction by ethyl acetate. The separation was achieved by using a reversed-phase C18 column with a 16 min gradient elution protocol consisting of water (0.1%, v/v, formic acid) and 0-70% ACN (0.1%, v/v, formic acid). The lower limit of quantitation for (-)-epiafzelechin was found to be 12.5 ng/mL. This method exhibited a good linearity (r(2) = 0.992). The intra-day and inter-day precision were within 12%, while the accuracy was between 97.6 and 113.4%. A quantity of 10 mg/kg synthetic (-)epiafzelechin was administered to C57BL/6J mice by intravenous (i.v.) and intraperitoneal (i.p.) injections and the blood was collected at different time points. The plasma was then analyzed by the UPLC-MS/MS method, and the plasma drug concentration-time curves for i.v. and i.p. (-)-epiafzelechin injection were constructed. The maximum concentrations (C-max) of (-)-epiafzelechin in blood by i.v. and i.p. injection were found to be 10.6 and 6.0 mu g/mL, respectively, while the time for reaching C-max in i.p. injection was found to be 15 min. The distribution half-lives of (-)-epiafzelechin after i.v. and i.p. injection were found to be 7.0 and 12.6 min, respectively. Some of the PK parameters were found to be similar in both i.v. and i.p. injections of (-)-epiafzelechin owing to its high solubility in water. | Keywords: | (-)-Epiafzelechin Intravenous Intraperitoneal Pharmacokinetics UPLC-MS/MS |
Publisher: | Elsevier | Journal: | Journal of chromatography b-analytical technologies in the biomedical and life sciences | ISSN: | 1570-0232 | DOI: | 10.1016/j.jchromb.2014.07.028 | Rights: | © 2014 Elsevier B.V. All rights reserved. © 2014. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1063_EAF_PK_manuscript__2014_for_RGC.pdf | Pre-Published version | 1.12 MB | Adobe PDF | View/Open |
Page views
98
Last Week
1
1
Last month
Citations as of Apr 14, 2024
Downloads
63
Citations as of Apr 14, 2024
SCOPUSTM
Citations
10
Last Week
0
0
Last month
Citations as of Apr 5, 2024
WEB OF SCIENCETM
Citations
10
Last Week
0
0
Last month
Citations as of Apr 18, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.